Position in EXEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$46,416,787
+$5,476,097 QoQ
Shares Held
853,093
-10.6% QoQ
Ownership
0.344%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#50
of 739 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 35%
Shared 0%
None 65%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Allianz Asset Management GmbH holds $690,566,615 across 64 Biotechnology names. EXEL ranks #4 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
327,683 | $204,323,456 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
564,696 | $136,074,794 | |
| 3 | MRNA |
Moderna, Inc.
|
989,897 | $69,322,486 | |
| 4 | EXEL |
Exelixis, Inc.
This page
|
853,093 | $46,416,787 | |
| 5 | APGE |
Apogee Therapeutics, Inc.
|
179,500 | $23,825,035 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
400,036 | $22,890,059 | |
| 7 | FTRE |
Fortrea Holdings Inc.
|
1,127,337 | $19,615,663 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
706,664 | $17,878,599 |
All Filings in EXEL
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $46,416,787 | 853,093 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $40,940,690 | 954,551 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $63,972,075 | 1,459,550 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $101,719,750 | 2,462,948 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $42,864,625 | 972,428 | Shares | Defined | 2025-07-28 | |
| 2025-03-31 | $19,176,543 | 519,408 | Shares | Defined | 2025-05-05 | |
| 2024-12-31 | $3,186,310 | 95,685 | Shares | Defined | 2025-02-03 | |
| 2024-09-30 | $5,075,197 | 195,576 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $4,611,158 | 205,214 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $4,112,693 | 173,312 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $2,992,128 | 124,724 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $2,425,393 | 111,002 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,317,297 | 121,261 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $27,219,981 | 1,402,369 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $22,469,055 | 1,400,814 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $24,788,903 | 1,580,925 | Shares | Defined | 2022-11-08 | |
| 2022-06-30 | $31,557,123 | 1,515,712 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $28,248,542 | 1,246,076 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $20,487,730 | 1,120,773 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $23,564,187 | 1,114,673 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $7,275,246 | 399,300 | Shares | Defined | 2021-08-16 | |
| 2020-09-30 | $981,423 | 40,140 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $2,940,578 | 123,866 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,077,627 | 62,580 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||